Have questions on the latest news concerning REGENXBIO and its halted gene therapy programs for CLN2 Batten disease? Join us for a webinar on Thursday, November 30, at 6 p.m. EST.
This webinar will be hosted by BDSRA Head of Research & Medical Affairs Dr. Ineka Whiteman, who’ll be joined by BDSRA board members Dr. David Pearce and Dr. Fernanda Leal-Pardinas. Dr. Whiteman will provide the latest news on REGENXBIO’s Batten disease programs, followed by a Q&A.
Those who wish to attend MUST register. Register before the webinar’s start time on Nov. 30.
